Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective

Neurology

Volumn 67, Issue 1, 2006, Pages 125-130

  Clemens, Stefan ^a   Rye, David ^a   Hochman, Shawn ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE; TYROSINE 3 MONOOXYGENASE; DOPAMINE RECEPTOR STIMULATING AGENT;

ADRENERGIC SYSTEM; CENTRAL NERVOUS SYSTEM; DOPAMINE METABOLISM; DORSAL RAPHE NUCLEUS; HUMAN; HYPOTHALAMUS; LOCOMOTION; MOTOR ACTIVITY; MUSCLE SPINDLE AFFERENT NERVE; NEOCORTEX; NONHUMAN; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD; ANIMAL; BIOLOGICAL MODEL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DOPAMINE; DOPAMINE AGENTS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, DOPAMINE D3; RESTLESS LEGS SYNDROME; SPINAL CORD;

EID: 33746784318     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000223316.53428.c9     Document Type: Article

References (73)

1. Ekbom KA. Restless legs syndrome. Acta Med Scand 1945;158:4-122.
2. Odin P. Diagnostic criteria. In: Chaudhuri, KR, Odin P, Olanow CW, eds. Restless legs syndrome. London/New York: Taylor & Francis, 2004:9-20.
3. Hening WA. Restless legs syndrome: a sensorimotor disorder of sleep/wake motor regulation. Curr Neurol Neurosci Rep 2002;2:186-196.
4. Meilak C, Dhawan V, Chaudhuri KR. Clinical features (of RLS). In: Chaudhuri, KR, Odin P, Olanow CW, eds. Restless legs syndrome. London/New York: Taylor & Francis, 2004:49-56.
5. Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000;54:1609-1616.
6. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-147.
7. Barriere G, Cazalets JR, Bioulac B, Tison F, Ghorayeb I. The restless legs syndrome. Prog Neurobiol 2005;77:139-165.
8. Chaudhuri KR, Odin P, Olanow CW, eds. Restless legs syndrome. London/New York: Taylor & Francis, 2004.
9. Ondo WG. Restless legs syndrome. Curr Neurol Neurosci Rep 2005;5:266-274.
10. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005;4:465-475.
11. Jöbges M, Odin P, Chaudhuri KR. Epidemiology. In: Chaudhuri, KR, Odin P, Olanow CW, eds. Restless legs syndrome. London/New York: Taylor & Francis, 2004:20-36.
12. Masood A, Phillips B. Epidemiology of restless legs syndrome. In: Chokorvarty S, Hening WA, Walters AS, eds. Sleep and movement disorders. Oxford: Butterworth-Heinemann, 2002:316-321.
13. Desautels A, Turecki G, Montplaisir J, et al. Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 2002;59:215-219.
14. Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001;69:1266-1270.
15. Earley C, Allen R, Beard J, Connor J. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 2000;62:623-628.
16. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-309.
17. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 2004;5:385-391.
18. Khaldy H, Leon J, Escames G, Bikjdaouene L, Garcia JJ, Acuna-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology 2002;75:201-208.
19. Desautels A, Turecki G, Montplaisir J, et al. Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology 2001;57:1304-1306.
20. Stiasny-Kolster K, Moller JC, Zschocke J, et al. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Mov Disord 2004;19:192-196.
21. Wetter TC, Eisensehr I, Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med 2004;5:401-406.
22. Garraway SM, Hochman S. Modulatory actions of serotonin, norepinephrine, dopamine, and acetylcholine in spinal cord deep dorsal horn neurons. J Neurophysiol 2001;86:2183-2194.
23. Gladwell SJ, Coote JH. Fast excitatory post synaptic potentials and their response to catecholaminergic antagonists in rat sympathetic preganglionic neurones in vitro. Neurosci Lett 1999;268:89-92.
24. Barrière G, Mellen N, Cazalets J. Neuromodulation of the locomotor network by dopamine in the isolated spinal cord of newborn rat. J Neurophysiol 2004;19:1325-1335.
25. Gladwell SJ, Coote JH. Inhibitory and indirect excitatory effects of dopamine on sympathetic preganglionic neurones in the neonatal rat spinal cord in vitro. Brain Res 1999;818:397-407.
26. Hartmann M, Pfister R, Pfadenhauer K. Restless legs syndrome associated with spinal cord lesions. J Neurol Neurosurg Psychiatry 1999;66:688-689.
27. Lee MS, Lyoo CH, Kim WC, Kang HJ. Periodic bursts of rhythmic dyskinesia associated with spinal anesthesia. Mov Disord 1997;12:816-817.
28. Willis T. Of the diseases of the brain and the genus nervosum. In: The London practice of physick. London: Bassett and Crooke, 1685.
29. Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2000;15:154-158.
30. Accili D, Fishburn CS, Drago J, et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 1996;93:1945-1949.
31. Hue GE, Decker MJ, Solomon IG, Rye DB. Increased wakefulness and hyper-responsivity to novel environments in mice lacking functional dopamine D3 receptors. Soc Neurosci 2003;616:16.
32. Wang D, Sutherland D, McErlane SA, Soja PJ. Long-lasting reduction in rat sensory thresholds following ablation of diencephalic A11 dopamine (DA) nuclei. In: Ann Soc Neurosci Meeting, 2005. Washington, DC: Society for Neuroscience, 2005: 623.621.
33. Clemens S, Hochman S. Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice. J Neurosci 2004;24:11337-11345.
34. Clemens S, Sawchuk MA, Hochman S. Reversal of the circadian expression of tyrosine-hydroxylase but not nitric oxide synthase levels in the spinal cord of D3 receptor knockout mice. Neuroscience 2005;133:353-357.
35. Jaber M, Robinson SW, Missale C, Caron MG. Dopamine receptors and brain function. Neuropharmacology 1996;35:1503-1519.
36. Hornykiewicz O. Chemical neuroanatomy of the basal ganglia: normal and in Parkinson's disease. J Chem Neuroanat 2001;22:3-12.
37. Majovski LV, Jacques S, Hartz G, Fogwell LA. Dopaminergic (DA) systems: their role in pathological neurobehavioral symptoms. Neurosurgery 1981;9:751-757.
38. Schultz W. Reward signaling by dopamine neurons. Neuroscientist 2001;7:293-302.
39. Skagerberg G, Bjorklund A, Lindvall O, Schmidt RH. Origin and termination of the diencephalo-spinal dopamine system in the rat. Brain Res Bull 1982;9:237-244.
40. Skagerberg G, Lindvall O. Organization of diencephalic dopamine neurones projecting to the spinal cord in the rat. Brain Res 1985;342:340-351.
41. Qu S, Ondo WG, Zhang X, Xie WJ, Pan TH, Le WD. Projections of diencephalic dopamine neurons into the spinal cord in mice. Exp Brain Res 2006;168:152-156.
42. Manger PR, Fuxe K, Ridgway SH, Siegel JM. The distribution and morphological characteristics of catecholaminergic cells in the diencephalon and midbrain of the bottlenose dolphin (Tursiops truncatus). Brain Behav Evol 2004;64:42-60.
43. Takada M, Li ZK, Hattori T. Single thalamic dopaminergic neurons project to both the neocortex and spinal cord. Brain Res 1988;455:346-352.
44. Peyron C, Luppi PH, Kitahama K, Fort P, Hermann DM, Jouvet M. Origin of the dopaminergic innervation of the rat dorsal raphe nucleus. Neuroreport 1995;6:2527-2531.
45. Holstege JC, Dijken HV, Buijs RM, Goedkengt H, Gosens T, Bongers CM. Distribution of dopamine immunoreactivity in the rat, cat, and monkey spinal cord. J Comp Neurol 1996;376:631-652.
46. Lindvall O, Bjorklund A, Skagerberg G. Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol 1983;14:255-260.
47. Winkelman JW. The evoked heart rate response to periodic leg movements of sleep. Sleep 1999;22:575-580.
48. Sautel F, Griffon N, Levesque D, Pilon C, Schwartz JC, Sokoloff P. A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport 1995;6:329-332.
49. Commissiong JW, Sedgwick EM. Letter: Dopamine and noradrenaline in human spinal cord. Lancet 1975;1:347.
50. Carp JS, Anderson RJ. Dopamine receptor-mediated depression of spinal monosynaptic transmission. Brain Res 1982;242:247-254.
51. Michaud M, Chabli A, Lavigne G, Montplaisir J. Arm restlessness in patients with restless legs syndrome. Mov Disord 2000;15:289-293.
52. Carlsson A, Svennerholm L, Winblad B. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl 1980;280:75-85.
53. Wolpaw JR, Seegal RF. Diurnal rhythm in the spinal stretch reflex. Brain Res 1982;244:365-369.
54. Guyton AC, Hall JE. Textbook of medical physiology. Philadelphia: W.B. Saunders, 1996.
55. Barker D, Saito M. Autonomic innervation of receptors and muscle fibres in cat skeletal muscle. Proc R Soc Lond B Biol Sci 1981;212:317-332.
56. Fleetwood-Walker SM, Hope PJ, Mitchell R. Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J Physiol 1988;399:335-348.
57. Seagrove LC, Suzuki R, Dickenson AH. Electrophysiological characterisations of rat lamina I dorsal horn neurones and the involvement of excitatory amino acid receptors. Pain 2004;108:76-87.
58. Stiasny-Kolster K, Magerl W, Oertel WH, Moller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004;127:773-782.
59. Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. Sleep loss and REM sleep are hyperalgesic. Sleep 2006;29:145-151.
60. Schattschneider J, Bode A, Wasner G, Binder A, Deuschl G, Baron R. Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. J Neurol 2004;251:977-982.
61. Meyerson BA, Linderoth B. Mechanisms of spinal cord stimulation in neuropathic pain. Neurol Res 2000;22:285-292.
62. Melzack R. Pain: past, present and future. Can J Exp Psychol 1993;47:615-629.
63. Robinson SE, Austin MJ, Gibbens DM. The role of serotonergic neurons in dorsal raphe, median raphe and anterior hypothalamic pressor mechanisms. Neuropharmacology 1985;24:51-58.
64. Lakke EA. The projections to the spinal cord of the rat during development: a timetable of descent. Adv Anat Embryol Cell Biol 1997;135:I-XIV, 1-143.
65. Pickering AE, Spanswick D, Logan SD. 5-Hydoxytryptamine evokes depolarizations and membrane potential oscillations in rat sympathetic preganglionic neurones. J Physiol. 1994;480(pt 1):109-121.
66. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005;28:891-898.
67. Nofzinger EA, Fasiczka A, Berman S, Thase ME. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry 2000;61:858-862.
68. Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology 2004;63:1065-1069.
69. Ondo W. Secondary restless legs syndrome. In: Chaudhuri, KR, Odin P, Olanow CW, eds. Restless legs syndrome. London/New York: Taylor & Francis, 2004:57-84.
70. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141.
71. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001;16:1159-1163.
72. Stiasny K, Wetter TC, Winkelmann J, et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 2001;56:1399-1402.
73. Stiasny-Kolster K, Kohnen R, Schollmayer E, Moller JC, Oertel WH. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord 2004;19:1432-1438.